BIAF

bioAffinity Technologies, Inc.

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$2.34

Price (1 Year)

$60 $2.34

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %6.8 / %30
Non-compliant assets / Total market cap %0 / %30
Non-compliant revenue / Total income %0.5 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates through two segments: Diagnostic Research and Development; and Laboratory Services.

Website

Analysis (Turkish): BIAF Hissesi Caiz mi, Helal mi? bioAffinity Technologies, Inc. Katılım Analizi